Late Breaking Abstract - Protection by budesonide against clinically important deteriorations (CID) in patients with COPD is dependent on blood eosinophil counts (EOS)

Late Breaking Abstract - Protection by budesonide against clinically important deteriorations (CID) in patients with COPD is dependent on blood eosinophil counts (EOS)

Bibliografski detalji
Glavni autori:	Bafadhel, M, Sing, D, Jenkins, C, Peterson, S, Bengtsson, T, Fageras, M
Format:	Conference item
Izdano:	European Respiratory Society 2018

Slični predmeti

Adding budesonide to formoterol reduces risk of clinically important deteriorations (CID) in moderate to very severe COPD
od: Bafadhel, M, i dr.
Izdano: (2018)

Modelling peripheral blood eosinophils to identify response to budesonide in COPD: a post-hoc analysis
od: Bafadhel, M, i dr.
Izdano: (2017)

Investigating blood eosinophil count thresholds in patients with COPD
od: Russell, R, i dr.
Izdano: (2018)

Late breaking abstract - Dose-ranging study of mepolizumab in eosinophilic COPD
od: Pavord, I, i dr.
Izdano: (2017)

Case series of long-term macrolide therapy effect on eosinophil count in COPD
od: Asciak, R, i dr.
Izdano: (2017)

Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials
od: Bafadhel, M, i dr.
Izdano: (2018)

Blood eosinophil count and exacerbation risk in patients with COPD.
od: Kerkhof, M, i dr.
Izdano: (2017)

Characterising non-eosinophilic COPD
od: Hambleton, K, i dr.
Izdano: (2015)

Eosinophils in COPD: just another biomarker?
od: Bafadhel, M, i dr.
Izdano: (2017)

Benefits of Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate on COPD Exacerbations, Lung Function, Symptoms, and Quality of Life Across Blood Eosinophil Ranges: A Post-Hoc Analysis of Data from ETHOS
od: Bafadhel M, i dr.
Izdano: (2022-12-01)

Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis
od: Antonella Casiraghi, i dr.
Izdano: (2020-03-01)

The peripheral blood eosinophil count as a biomarker of eosinophilic airway inflammation in patients with asthma and COPD. Experience from a single centre
od: Shrimanker, R, i dr.
Izdano: (2017)

Variability of blood eosinophil count and prognosis of COPD exacerbations
od: Sandra Martínez-Gestoso, i dr.
Izdano: (2021-01-01)

Blood eosinophil count as a prognostic biomarker in COPD
od: Oh YM, i dr.
Izdano: (2018-10-01)

Eosinophil migration is enhanced towards IL-5 and eotaxin in COPD
od: Lababidi, R, i dr.
Izdano: (2017)

Blood eosinophil count and GOLD stage predict response to maintenance azithromycin treatment in COPD patients with frequent exacerbations
od: Djamin, R, i dr.
Izdano: (2019)

Mucoadhesive Budesonide Solution for the Treatment of Pediatric Eosinophilic Esophagitis
od: Antonio Spennacchio, i dr.
Izdano: (2024-04-01)

Clinically Important Deterioration (CID) and Ageing in COPD: A Systematic Review and Meta-Regression Analysis According to PRISMA Statement
od: Manzetti GM, i dr.
Izdano: (2023-10-01)

Association between blood eosinophil count and small airway eosinophils in smokers with and without COPD
od: Tomoki Maetani, i dr.
Izdano: (2023-10-01)

Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility and high eosinophil counts
od: Shigeo Muro, i dr.
Izdano: (2021-06-01)

Can NPT be used to distinguish eosinophilic inflammatory phenotypes in COPD?
od: Hambleton, K, i dr.
Izdano: (2016)

Prediction value of neutrophil and eosinophil count at risk of COPD exacerbation
od: Tzu-Tao Chen, i dr.
Izdano: (2023-12-01)

Current smoking reduces small airway eosinophil counts in COPD
od: Augusta Beech, i dr.
Izdano: (2024-01-01)

Corrections to: Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility and high eosinophil counts
od: Shigeo Muro, i dr.
Izdano: (2021-08-01)

Comparison of the peripheral blood eosinophil count using near-patient testing and standard automated laboratory measurement in healthy, asthmatic and COPD subjects
od: Hambleton, K, i dr.
Izdano: (2017)

Association between blood eosinophil count and risk of exacerbations in patients with COPD
od: Kerkhof, M, i dr.
Izdano: (2017)

Blood eosinophil count correlates with alveolar damage in emphysema-predominant COPD
od: Saya Nakamura, i dr.
Izdano: (2024-10-01)

Identification of COPD Inflammatory Endotypes Using Repeated Sputum Eosinophil Counts
od: Augusta Beech, i dr.
Izdano: (2022-10-01)

Longitudinal stability of blood eosinophil count strata in the COPD COSYCONET cohort
od: Greulich T, i dr.
Izdano: (2018-09-01)

Blood eosinophil count predicts treatment failure and hospital readmission for COPD
od: Marjan Kerkhof, i dr.
Izdano: (2020-11-01)

Budesonide/formoterol combination in COPD: a US perspective
od: Amir Sharafkhaneh, i dr.
Izdano: (2010-10-01)

Late breaking abstract - Resistomics of sputum from COPD and healthy subjects reveals bacterial load-related prevalence of antimicrobial-resistance-encoding genes
od: Ramsheh, M, i dr.
Izdano: (2018)

Delayed hypersensitivity reaction to orodispersible budesonide in a case with eosinophilic esophagitis
od: Caroline Michèle Andrist, i dr.
Izdano: (2020-12-01)

Clinical implications of blood eosinophil count in patients with non-asthma–COPD overlap syndrome COPD
od: Song JH, i dr.
Izdano: (2017-08-01)

Blood Eosinophils and outcomes in severe hospitalized exacerbations of COPD
od: Bafadhel, M, i dr.
Izdano: (2016)

Copd in the ed: eosinophils, treatment and outcomes, data from the pre-award study
od: Russell, R, i dr.
Izdano: (2016)

Blood eosinophil count and airway epithelial transcriptome relationships in COPD versus asthma
od: George, L, i dr.
Izdano: (2019)

Eosinophil counts in first COPD hospitalizations: a comparison of health service utilization
od: Bélanger M, i dr.
Izdano: (2018-10-01)

Comparison of fluticasone propionate and budesonide on COPD macrophage and neutrophil function
od: Belchamber KBR, i dr.
Izdano: (2018-09-01)

Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis.
od: Bafadhel, M, i dr.
Izdano: (2014)